Ignite Creation Date:
2025-12-25 @ 12:31 AM
Ignite Modification Date:
2025-12-25 @ 10:38 PM
Study NCT ID:
NCT04784767
Status:
COMPLETED
Last Update Posted:
2025-06-17
First Post:
2021-03-03
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
PHASE 1 SARS-COV-2-Spike-Ferritin-Nanoparticle (SpFN) Vaccine With ALFQ Adjuvant for Prevention of COVID-19
Sponsor:
U.S. Army Medical Research and Development Command
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-05
Start Date Type:
ACTUAL
Primary Completion Date:
2023-03-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-10-30
Completion Date Type:
ACTUAL
First Submit Date:
2021-03-03
First Submit QC Date:
None
Study First Post Date:
2021-03-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-12
Last Update Post Date:
2025-06-17
Last Update Post Date Type:
ACTUAL